View Future GrowthLevima Advanced Materials 過去の業績過去 基準チェック /36Levima Advanced Materialsの収益は年間平均-30.9%の割合で減少していますが、 Chemicals業界の収益は年間 減少しています。収益は年間5.6% 4.1%割合で 減少しています。 Levima Advanced Materialsの自己資本利益率は5.1%であり、純利益率は5.4%です。主要情報-30.88%収益成長率-31.90%EPS成長率Chemicals 業界の成長12.10%収益成長率-4.09%株主資本利益率5.14%ネット・マージン5.38%前回の決算情報31 Mar 2026最近の業績更新お知らせ • Mar 31Levima Advanced Materials Corporation to Report Q1, 2026 Results on Apr 23, 2026Levima Advanced Materials Corporation announced that they will report Q1, 2026 results on Apr 23, 2026お知らせ • Dec 31Levima Advanced Materials Corporation to Report Fiscal Year 2025 Results on Mar 28, 2026Levima Advanced Materials Corporation announced that they will report fiscal year 2025 results on Mar 28, 2026お知らせ • Sep 30Levima Advanced Materials Corporation to Report Q3, 2025 Results on Oct 15, 2025Levima Advanced Materials Corporation announced that they will report Q3, 2025 results on Oct 15, 2025お知らせ • Jul 02Levima Advanced Materials Corporation to Report First Half, 2025 Results on Aug 16, 2025Levima Advanced Materials Corporation announced that they will report first half, 2025 results on Aug 16, 2025お知らせ • Mar 31Levima Advanced Materials Corporation to Report Q1, 2025 Results on Apr 26, 2025Levima Advanced Materials Corporation announced that they will report Q1, 2025 results on Apr 26, 2025お知らせ • Dec 31Levima Advanced Materials Corporation to Report Fiscal Year 2024 Results on Mar 28, 2025Levima Advanced Materials Corporation announced that they will report fiscal year 2024 results on Mar 28, 2025すべての更新を表示Recent updatesBoard Change • May 20Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Na Sun was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.お知らせ • Mar 31Levima Advanced Materials Corporation to Report Q1, 2026 Results on Apr 23, 2026Levima Advanced Materials Corporation announced that they will report Q1, 2026 results on Apr 23, 2026お知らせ • Mar 28Levima Advanced Materials Corporation, Annual General Meeting, Apr 20, 2026Levima Advanced Materials Corporation, Annual General Meeting, Apr 20, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing Chinaお知らせ • Dec 31Levima Advanced Materials Corporation to Report Fiscal Year 2025 Results on Mar 28, 2026Levima Advanced Materials Corporation announced that they will report fiscal year 2025 results on Mar 28, 2026お知らせ • Sep 30Levima Advanced Materials Corporation to Report Q3, 2025 Results on Oct 15, 2025Levima Advanced Materials Corporation announced that they will report Q3, 2025 results on Oct 15, 2025お知らせ • Jul 02Levima Advanced Materials Corporation to Report First Half, 2025 Results on Aug 16, 2025Levima Advanced Materials Corporation announced that they will report first half, 2025 results on Aug 16, 2025お知らせ • Apr 23Levima Advanced Materials Corporation Approves Cash Dividend on A Shares for the Year 2024, Payable on April 29, 2025Levima Advanced Materials Corporation at its Annual General Meeting held on 18 April 2025, approved the Cash dividend (tax included) on A shares of CNY 0.60000000 per 10 shares for the year 2024. Record date is 28 April 2025. Ex-date is 29 April 2025. Payment date is 29 April 2025.お知らせ • Mar 31Levima Advanced Materials Corporation to Report Q1, 2025 Results on Apr 26, 2025Levima Advanced Materials Corporation announced that they will report Q1, 2025 results on Apr 26, 2025お知らせ • Mar 29Levima Advanced Materials Corporation Proposes Final Cash Dividend for the Year 2024Levima Advanced Materials Corporation announced the profit distribution proposal for the year 2024 as final cash dividend (tax included) of CNY 0.60000000 per 10 shares.お知らせ • Mar 28Levima Advanced Materials Corporation, Annual General Meeting, Apr 18, 2025Levima Advanced Materials Corporation, Annual General Meeting, Apr 18, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing Chinaお知らせ • Dec 31Levima Advanced Materials Corporation to Report Fiscal Year 2024 Results on Mar 28, 2025Levima Advanced Materials Corporation announced that they will report fiscal year 2024 results on Mar 28, 2025New Risk • Nov 14New major risk - Revenue and earnings growthEarnings have declined by 13% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (10% operating cash flow to total debt). Earnings have declined by 13% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.2% net profit margin).Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.024 (vs CN¥0.059 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.024 (down from CN¥0.059 in 3Q 2023). Revenue: CN¥1.65b (down 4.4% from 3Q 2023). Net income: CN¥37.6m (down 52% from 3Q 2023). Profit margin: 2.3% (down from 4.5% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.お知らせ • Sep 30Levima Advanced Materials Corporation to Report Q3, 2024 Results on Oct 26, 2024Levima Advanced Materials Corporation announced that they will report Q3, 2024 results on Oct 26, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥14.77, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 24% over the past year.Board Change • Sep 03High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Na Sun was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 01Second quarter 2024 earnings released: EPS: CN¥0.07 (vs CN¥0.13 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.07 (down from CN¥0.13 in 2Q 2023). Revenue: CN¥1.83b (up 12% from 2Q 2023). Net income: CN¥89.3m (down 50% from 2Q 2023). Profit margin: 4.9% (down from 11% in 2Q 2023). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.お知らせ • Jun 29Levima Advanced Materials Corporation to Report First Half, 2024 Results on Jul 27, 2024Levima Advanced Materials Corporation announced that they will report first half, 2024 results on Jul 27, 2024Reported Earnings • Apr 28First quarter 2024 earnings released: EPS: CN¥0.04 (vs CN¥0.11 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.04 (down from CN¥0.11 in 1Q 2023). Revenue: CN¥1.49b (down 5.6% from 1Q 2023). Net income: CN¥51.4m (down 65% from 1Q 2023). Profit margin: 3.5% (down from 9.3% in 1Q 2023). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.Declared Dividend • Apr 20Dividend reduced to CN¥0.08Dividend of CN¥0.08 is 60% lower than last year. Ex-date: 25th April 2024 Payment date: 25th April 2024 Dividend yield will be 0.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (24% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 36 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 85% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Mar 30Levima Advanced Materials Corporation to Report Q1, 2024 Results on Apr 27, 2024Levima Advanced Materials Corporation announced that they will report Q1, 2024 results on Apr 27, 2024Reported Earnings • Mar 29Full year 2023 earnings released: EPS: CN¥0.33 (vs CN¥0.65 in FY 2022)Full year 2023 results: EPS: CN¥0.33 (down from CN¥0.65 in FY 2022). Revenue: CN¥6.78b (down 17% from FY 2022). Net income: CN¥446.1m (down 49% from FY 2022). Profit margin: 6.6% (down from 11% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China.お知らせ • Mar 27Levima Advanced Materials Corporation, Annual General Meeting, Apr 16, 2024Levima Advanced Materials Corporation, Annual General Meeting, Apr 16, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing ChinaNew Risk • Feb 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.5x net interest cover). High level of non-cash earnings (28% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.6% average weekly change). Profit margins are more than 30% lower than last year (7.4% net profit margin).Valuation Update With 7 Day Price Move • Jan 31Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥14.36, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 63% over the past year.お知らせ • Dec 30Levima Advanced Materials Corporation to Report Fiscal Year 2023 Results on Mar 27, 2024Levima Advanced Materials Corporation announced that they will report fiscal year 2023 results on Mar 27, 2024Reported Earnings • Oct 31Third quarter 2023 earnings released: EPS: CN¥0.059 (vs CN¥0.24 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.059 (down from CN¥0.24 in 3Q 2022). Revenue: CN¥1.73b (down 30% from 3Q 2022). Net income: CN¥78.4m (down 76% from 3Q 2022). Profit margin: 4.5% (down from 13% in 3Q 2022). Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.お知らせ • Sep 30Levima Advanced Materials Corporation to Report Q3, 2023 Results on Oct 26, 2023Levima Advanced Materials Corporation announced that they will report Q3, 2023 results on Oct 26, 2023New Risk • Jul 23New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 55% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results.Upcoming Dividend • Apr 28Upcoming dividend of CN¥0.20 per share at 0.7% yieldEligible shareholders must have bought the stock before 05 May 2023. Payment date: 05 May 2023. Payout ratio is a comfortable 26% but the company is not cash flow positive. Trailing yield: 0.7%. Lower than top quartile of Chinese dividend payers (2.0%). Lower than average of industry peers (1.9%).Buying Opportunity • Mar 15Now 20% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥38.68, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 20%. Revenue is forecast to grow by 49% in 2 years. Earnings is forecast to grow by 123% in the next 2 years.Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥35.24, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 8.0% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥39.00 per share.Board Change • Nov 16High number of new and inexperienced directorsThere are 11 new directors who have joined the board in the last 3 years. The company's board is composed of: 11 new directors. No experienced directors. No highly experienced directors. Employee Representative Supervisor Jingjun Zhou is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Valuation Update With 7 Day Price Move • Nov 05Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥38.55, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 15x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥47.09 per share.Buying Opportunity • Oct 14Now 25% undervalued after recent price dropOver the last 90 days, the stock is down 2.4%. The fair value is estimated to be CN¥52.35, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 47% in 2 years. Earnings is forecast to grow by 104% in the next 2 years.Buying Opportunity • Sep 16Now 24% undervaluedOver the last 90 days, the stock is up 23%. The fair value is estimated to be CN¥57.48, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 48% in 2 years. Earnings is forecast to grow by 110% in the next 2 years.Valuation Update With 7 Day Price Move • Sep 07Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥48.13, the stock trades at a forward P/E ratio of 45x. Average forward P/E is 17x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥58.50 per share.Buying Opportunity • Aug 31Now 20% undervaluedOver the last 90 days, the stock is up 72%. The fair value is estimated to be CN¥57.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 46% in 2 years. Earnings is forecast to grow by 83% in the next 2 years.Reported Earnings • Jul 29Second quarter 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.21 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.26 (up from CN¥0.21 in 2Q 2021). Revenue: CN¥2.38b (up 18% from 2Q 2021). Net income: CN¥349.4m (up 29% from 2Q 2021). Profit margin: 15% (up from 13% in 2Q 2021). Over the next year, revenue is forecast to grow 22%, compared to a 42% growth forecast for the industry in China.Valuation Update With 7 Day Price Move • Jul 19Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥40.50, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 17x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥57.37 per share.Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improved over the past weekAfter last week's 24% share price gain to CN¥33.45, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 18x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥53.95 per share.Valuation Update With 7 Day Price Move • May 21Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥25.47, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 16x in the Chemicals industry in China.Reported Earnings • Apr 27First quarter 2022 earnings released: EPS: CN¥0.08 (vs CN¥0.20 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.08 (down from CN¥0.20 in 1Q 2021). Revenue: CN¥1.56b (down 14% from 1Q 2021). Net income: CN¥107.4m (down 60% from 1Q 2021). Profit margin: 6.9% (down from 15% in 1Q 2021). Over the next year, revenue is forecast to grow 27%, compared to a 43% growth forecast for the industry in China.Board Change • Apr 27High number of new and inexperienced directorsThere are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 1 experienced director. No highly experienced directors. Non-Employee Supervisor Rongguang Liu is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Apr 06Full year 2021 earnings released: EPS: CN¥0.82 (vs CN¥0.56 in FY 2020)Full year 2021 results: EPS: CN¥0.82 (up from CN¥0.56 in FY 2020). Revenue: CN¥7.58b (up 28% from FY 2020). Net income: CN¥1.09b (up 70% from FY 2020). Profit margin: 14% (up from 11% in FY 2020). Over the next year, revenue is forecast to grow 21%, compared to a 48% growth forecast for the industry in China.Board Change • Dec 10High number of new and inexperienced directorsThere are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 1 experienced director. No highly experienced directors. Non-Employee Supervisor Rongguang Liu is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.収支内訳Levima Advanced Materials の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史XSEC:003022 収益、費用、利益 ( )CNY Millions日付収益収益G+A経費研究開発費31 Mar 267,04437941133231 Dec 256,33830636330030 Sep 255,86928933928530 Jun 255,86625433828431 Mar 256,32025434130231 Dec 246,26823434432830 Sep 246,80822034033830 Jun 246,88426137434131 Mar 246,68935037532331 Dec 236,77844635130930 Sep 236,67649334030730 Jun 237,42673533332131 Mar 238,17790631934201 Jan 238,15786633333130 Sep 228,3321,04632034230 Jun 227,6931,00631232331 Mar 227,33392833829001 Jan 227,5811,09132027330 Sep 217,6361,04044824030 Jun 217,14895236922231 Mar 216,56181234519731 Dec 205,93164130416330 Sep 205,50153327311631 Dec 195,6745323132531 Dec 185,7952292601131 Dec 174,659552331231 Dec 164,0171883228質の高い収益: 003022 非現金収入 のレベルが高いです。利益率の向上: 003022の現在の純利益率 (5.4%)は、昨年(4%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 003022の収益は過去 5 年間で年間30.9%減少しました。成長の加速: 003022の過去 1 年間の収益成長率 ( 49% ) は、5 年間の平均 ( 年間-30.9%を上回っています。収益対業界: 003022の過去 1 年間の収益成長率 ( 49% ) はChemicals業界3.7%を上回りました。株主資本利益率高いROE: 003022の 自己資本利益率 ( 5.1% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/24 01:13終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Levima Advanced Materials Corporation 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。5 アナリスト機関Xiongwei JiaChina International Capital Corporation LimitedLin YangGuosen Securities Co., Ltd.Junjun ZhuHaitong International Research Limited2 その他のアナリストを表示
お知らせ • Mar 31Levima Advanced Materials Corporation to Report Q1, 2026 Results on Apr 23, 2026Levima Advanced Materials Corporation announced that they will report Q1, 2026 results on Apr 23, 2026
お知らせ • Dec 31Levima Advanced Materials Corporation to Report Fiscal Year 2025 Results on Mar 28, 2026Levima Advanced Materials Corporation announced that they will report fiscal year 2025 results on Mar 28, 2026
お知らせ • Sep 30Levima Advanced Materials Corporation to Report Q3, 2025 Results on Oct 15, 2025Levima Advanced Materials Corporation announced that they will report Q3, 2025 results on Oct 15, 2025
お知らせ • Jul 02Levima Advanced Materials Corporation to Report First Half, 2025 Results on Aug 16, 2025Levima Advanced Materials Corporation announced that they will report first half, 2025 results on Aug 16, 2025
お知らせ • Mar 31Levima Advanced Materials Corporation to Report Q1, 2025 Results on Apr 26, 2025Levima Advanced Materials Corporation announced that they will report Q1, 2025 results on Apr 26, 2025
お知らせ • Dec 31Levima Advanced Materials Corporation to Report Fiscal Year 2024 Results on Mar 28, 2025Levima Advanced Materials Corporation announced that they will report fiscal year 2024 results on Mar 28, 2025
Board Change • May 20Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Na Sun was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
お知らせ • Mar 31Levima Advanced Materials Corporation to Report Q1, 2026 Results on Apr 23, 2026Levima Advanced Materials Corporation announced that they will report Q1, 2026 results on Apr 23, 2026
お知らせ • Mar 28Levima Advanced Materials Corporation, Annual General Meeting, Apr 20, 2026Levima Advanced Materials Corporation, Annual General Meeting, Apr 20, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing China
お知らせ • Dec 31Levima Advanced Materials Corporation to Report Fiscal Year 2025 Results on Mar 28, 2026Levima Advanced Materials Corporation announced that they will report fiscal year 2025 results on Mar 28, 2026
お知らせ • Sep 30Levima Advanced Materials Corporation to Report Q3, 2025 Results on Oct 15, 2025Levima Advanced Materials Corporation announced that they will report Q3, 2025 results on Oct 15, 2025
お知らせ • Jul 02Levima Advanced Materials Corporation to Report First Half, 2025 Results on Aug 16, 2025Levima Advanced Materials Corporation announced that they will report first half, 2025 results on Aug 16, 2025
お知らせ • Apr 23Levima Advanced Materials Corporation Approves Cash Dividend on A Shares for the Year 2024, Payable on April 29, 2025Levima Advanced Materials Corporation at its Annual General Meeting held on 18 April 2025, approved the Cash dividend (tax included) on A shares of CNY 0.60000000 per 10 shares for the year 2024. Record date is 28 April 2025. Ex-date is 29 April 2025. Payment date is 29 April 2025.
お知らせ • Mar 31Levima Advanced Materials Corporation to Report Q1, 2025 Results on Apr 26, 2025Levima Advanced Materials Corporation announced that they will report Q1, 2025 results on Apr 26, 2025
お知らせ • Mar 29Levima Advanced Materials Corporation Proposes Final Cash Dividend for the Year 2024Levima Advanced Materials Corporation announced the profit distribution proposal for the year 2024 as final cash dividend (tax included) of CNY 0.60000000 per 10 shares.
お知らせ • Mar 28Levima Advanced Materials Corporation, Annual General Meeting, Apr 18, 2025Levima Advanced Materials Corporation, Annual General Meeting, Apr 18, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing China
お知らせ • Dec 31Levima Advanced Materials Corporation to Report Fiscal Year 2024 Results on Mar 28, 2025Levima Advanced Materials Corporation announced that they will report fiscal year 2024 results on Mar 28, 2025
New Risk • Nov 14New major risk - Revenue and earnings growthEarnings have declined by 13% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (10% operating cash flow to total debt). Earnings have declined by 13% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.2% net profit margin).
Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.024 (vs CN¥0.059 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.024 (down from CN¥0.059 in 3Q 2023). Revenue: CN¥1.65b (down 4.4% from 3Q 2023). Net income: CN¥37.6m (down 52% from 3Q 2023). Profit margin: 2.3% (down from 4.5% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.
お知らせ • Sep 30Levima Advanced Materials Corporation to Report Q3, 2024 Results on Oct 26, 2024Levima Advanced Materials Corporation announced that they will report Q3, 2024 results on Oct 26, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥14.77, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 24% over the past year.
Board Change • Sep 03High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Na Sun was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 01Second quarter 2024 earnings released: EPS: CN¥0.07 (vs CN¥0.13 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.07 (down from CN¥0.13 in 2Q 2023). Revenue: CN¥1.83b (up 12% from 2Q 2023). Net income: CN¥89.3m (down 50% from 2Q 2023). Profit margin: 4.9% (down from 11% in 2Q 2023). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.
お知らせ • Jun 29Levima Advanced Materials Corporation to Report First Half, 2024 Results on Jul 27, 2024Levima Advanced Materials Corporation announced that they will report first half, 2024 results on Jul 27, 2024
Reported Earnings • Apr 28First quarter 2024 earnings released: EPS: CN¥0.04 (vs CN¥0.11 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.04 (down from CN¥0.11 in 1Q 2023). Revenue: CN¥1.49b (down 5.6% from 1Q 2023). Net income: CN¥51.4m (down 65% from 1Q 2023). Profit margin: 3.5% (down from 9.3% in 1Q 2023). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.
Declared Dividend • Apr 20Dividend reduced to CN¥0.08Dividend of CN¥0.08 is 60% lower than last year. Ex-date: 25th April 2024 Payment date: 25th April 2024 Dividend yield will be 0.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (24% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 36 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 85% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Mar 30Levima Advanced Materials Corporation to Report Q1, 2024 Results on Apr 27, 2024Levima Advanced Materials Corporation announced that they will report Q1, 2024 results on Apr 27, 2024
Reported Earnings • Mar 29Full year 2023 earnings released: EPS: CN¥0.33 (vs CN¥0.65 in FY 2022)Full year 2023 results: EPS: CN¥0.33 (down from CN¥0.65 in FY 2022). Revenue: CN¥6.78b (down 17% from FY 2022). Net income: CN¥446.1m (down 49% from FY 2022). Profit margin: 6.6% (down from 11% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China.
お知らせ • Mar 27Levima Advanced Materials Corporation, Annual General Meeting, Apr 16, 2024Levima Advanced Materials Corporation, Annual General Meeting, Apr 16, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing China
New Risk • Feb 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.5x net interest cover). High level of non-cash earnings (28% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.6% average weekly change). Profit margins are more than 30% lower than last year (7.4% net profit margin).
Valuation Update With 7 Day Price Move • Jan 31Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥14.36, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 63% over the past year.
お知らせ • Dec 30Levima Advanced Materials Corporation to Report Fiscal Year 2023 Results on Mar 27, 2024Levima Advanced Materials Corporation announced that they will report fiscal year 2023 results on Mar 27, 2024
Reported Earnings • Oct 31Third quarter 2023 earnings released: EPS: CN¥0.059 (vs CN¥0.24 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.059 (down from CN¥0.24 in 3Q 2022). Revenue: CN¥1.73b (down 30% from 3Q 2022). Net income: CN¥78.4m (down 76% from 3Q 2022). Profit margin: 4.5% (down from 13% in 3Q 2022). Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.
お知らせ • Sep 30Levima Advanced Materials Corporation to Report Q3, 2023 Results on Oct 26, 2023Levima Advanced Materials Corporation announced that they will report Q3, 2023 results on Oct 26, 2023
New Risk • Jul 23New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 55% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results.
Upcoming Dividend • Apr 28Upcoming dividend of CN¥0.20 per share at 0.7% yieldEligible shareholders must have bought the stock before 05 May 2023. Payment date: 05 May 2023. Payout ratio is a comfortable 26% but the company is not cash flow positive. Trailing yield: 0.7%. Lower than top quartile of Chinese dividend payers (2.0%). Lower than average of industry peers (1.9%).
Buying Opportunity • Mar 15Now 20% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥38.68, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 20%. Revenue is forecast to grow by 49% in 2 years. Earnings is forecast to grow by 123% in the next 2 years.
Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥35.24, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 8.0% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥39.00 per share.
Board Change • Nov 16High number of new and inexperienced directorsThere are 11 new directors who have joined the board in the last 3 years. The company's board is composed of: 11 new directors. No experienced directors. No highly experienced directors. Employee Representative Supervisor Jingjun Zhou is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Valuation Update With 7 Day Price Move • Nov 05Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥38.55, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 15x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥47.09 per share.
Buying Opportunity • Oct 14Now 25% undervalued after recent price dropOver the last 90 days, the stock is down 2.4%. The fair value is estimated to be CN¥52.35, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 47% in 2 years. Earnings is forecast to grow by 104% in the next 2 years.
Buying Opportunity • Sep 16Now 24% undervaluedOver the last 90 days, the stock is up 23%. The fair value is estimated to be CN¥57.48, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 48% in 2 years. Earnings is forecast to grow by 110% in the next 2 years.
Valuation Update With 7 Day Price Move • Sep 07Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥48.13, the stock trades at a forward P/E ratio of 45x. Average forward P/E is 17x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥58.50 per share.
Buying Opportunity • Aug 31Now 20% undervaluedOver the last 90 days, the stock is up 72%. The fair value is estimated to be CN¥57.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 46% in 2 years. Earnings is forecast to grow by 83% in the next 2 years.
Reported Earnings • Jul 29Second quarter 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.21 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.26 (up from CN¥0.21 in 2Q 2021). Revenue: CN¥2.38b (up 18% from 2Q 2021). Net income: CN¥349.4m (up 29% from 2Q 2021). Profit margin: 15% (up from 13% in 2Q 2021). Over the next year, revenue is forecast to grow 22%, compared to a 42% growth forecast for the industry in China.
Valuation Update With 7 Day Price Move • Jul 19Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥40.50, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 17x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥57.37 per share.
Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improved over the past weekAfter last week's 24% share price gain to CN¥33.45, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 18x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥53.95 per share.
Valuation Update With 7 Day Price Move • May 21Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥25.47, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 16x in the Chemicals industry in China.
Reported Earnings • Apr 27First quarter 2022 earnings released: EPS: CN¥0.08 (vs CN¥0.20 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.08 (down from CN¥0.20 in 1Q 2021). Revenue: CN¥1.56b (down 14% from 1Q 2021). Net income: CN¥107.4m (down 60% from 1Q 2021). Profit margin: 6.9% (down from 15% in 1Q 2021). Over the next year, revenue is forecast to grow 27%, compared to a 43% growth forecast for the industry in China.
Board Change • Apr 27High number of new and inexperienced directorsThere are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 1 experienced director. No highly experienced directors. Non-Employee Supervisor Rongguang Liu is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Apr 06Full year 2021 earnings released: EPS: CN¥0.82 (vs CN¥0.56 in FY 2020)Full year 2021 results: EPS: CN¥0.82 (up from CN¥0.56 in FY 2020). Revenue: CN¥7.58b (up 28% from FY 2020). Net income: CN¥1.09b (up 70% from FY 2020). Profit margin: 14% (up from 11% in FY 2020). Over the next year, revenue is forecast to grow 21%, compared to a 48% growth forecast for the industry in China.
Board Change • Dec 10High number of new and inexperienced directorsThere are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 1 experienced director. No highly experienced directors. Non-Employee Supervisor Rongguang Liu is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.